Our cohort selection may also have led to a bias to evaluate the association between DLL3 expression and prognosis (OS and DFS) in SCLC patients, since the better outcome of the early-stage SCLC patients in our study. The gene discussed is DLL3; the disease is small cell lung carcinoma.